Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

GATIFLOXACIN 0.5% EYE DROPS

GATIFLOXACIN
$8.9796per ML

Strength

5 mg/mL

Manufacturer

Leading Pharma, LLC

NDC

69315033102

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Last Updated

4/22/2026

Active Ingredients

GATIFLOXACIN ANHYDROUS

Approval Type

Generic (ANDA)

FDA Application

ANDA213542

On Market Since

10/6/2025

Pharmacological Classes

Quinolone Antimicrobial
Quinolones

Price History

1W

0.0%

1M

-8.7%

3M

-12.3%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-9.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

CIPROFLOXACN-D5W 400 MG/200 ML
Generic
25021011487•Sagent Pharmaceuticals
$0.0123
per ML
CIPROFLOXACIN HCL 250 MG TAB
Generic
00143992701•Hikma Pharmaceuticals USA Inc.
$0.0880
per EA
CIPROFLOXACIN HCL 250 MG TAB
Generic
16571041110•Rising Pharma Holdings Inc.
$0.0880
per EA
CIPROFLOXACIN HCL 250 MG TAB
Generic
43547068810•Solco Healthcare US LLC
$0.0880
per EA
CIPROFLOXACIN HCL 250 MG TAB
Generic
59651086601•Aurobindo Pharma Limited
$0.0880
per EA
CIPROFLOXACIN HCL 250 MG TAB
Generic
61442022201•Carlsbad Technology Inc.
$0.0880
per EA
CIPROFLOXACIN HCL 250 MG TAB
Generic
62135030801•Chartwell RX LLC
$0.0880
per EA
CIPROFLOXACIN HCL 250 MG TAB
Generic
65862007601•Aurobindo Pharma Limited
$0.0880
per EA
CIPROFLOXACIN HCL 250 MG TAB
Generic
69367038501•Westminster Pharmaceuticals LLC
$0.0880
per EA
CIPROFLOXACIN HCL 250 MG TAB
Generic
16252051401•Teva Pharmaceuticals USA Inc.
$0.0886
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy